Project Grant R01ES035710

Award Date 6/20/25
Completion Date 3/31/30
Dollars Obligated $527K
Federal Grant Program
93.113
Assistance Type
Project Grant
Place of Performance
Ann Arbor, MI 48109, USA
Similar Awards
This Project Grant award, valued at $1,054,600 and awarded on September 1, 2024, supports research conducted by the Regents of the University of Michigan under the Environmental Health (CFDA 93.113) program of the National Institute of Environmental Health Sciences (NIEHS). The goal of this research is to investigate the mechanisms underlying impaired epithelial regeneration and fibrosis in silicosis and asbestosis, two progressive fibrotic lung diseases. The researchers aim to define distinct...
This $651,019 Project Grant award from the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) is funding research to elucidate the mechanisms behind dysfunctional epithelial repair processes that contribute to the development of pulmonary fibrosis. The research aims to identify factors driving aberrant epithelial cell states, determine the role of HIF signaling in preventing functional alveolar repair, and investigate niche-specific mechanisms regulating...
This Project Grant award of $544,610 from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) will support research to investigate the role of fibroblast-macrophage interactions and hedgehog signaling in mediating metabolic reprogramming and progression of asbestos-induced toxicity. The research will utilize human lung tissue, co-culture experiments, and transgenic mouse models to: 1) determine which macrophage subsets exhibit...
The National Institute of Environmental Health Sciences (NIEHS) awarded a Project Grant under the Environmental Health (CFDA 93.113) federal grant program to the Regents of the University of Michigan in the amount of $292,368. The award, effective September 1, 2024 through March 31, 2026, will support research to "disentangle the drivers and dangers of toxic cyanobacteria biosynthetic heterogeneity in cyanobacterial harmful algal blooms (CyanoHABs)." The research aims to identify the...
This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) provides $683,564 to The Trustees of the University of Pennsylvania to conduct research on alveolar epithelial stress signaling in lung fibrosis. The key objectives are to determine how aberrant transitional epithelial cells contribute to fibrosis, and to define how the PERK-ISR signaling pathway impacts epithelial differentiation and promotes fibrosis. The research will...
This federal Project Grant award from the National Institute of Environmental Health Sciences (NIEHS) under the Environmental Health (CFDA 93.113) program provides $241,811 to the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University to investigate the relationship between air pollution exposure, environmental injustice, and progressive pulmonary fibrosis (PPF) in patients with interstitial lung disease. The key objectives are to: (1) assess the impact of air pollution...
The National Institutes of Health National Institute of Environmental Health Sciences awarded a $924,612 Project Grant to the California State University, East Bay Foundation, Inc. under the Environmental Health (CFDA 93.113) federal grant program. The grant will fund research from August 2022 to July 2025 to advance chemical risk assessment and predictive toxicology through the development, validation and integration of high-throughput mechanistic in vitro assays. Specifically, the grantee will...
This $5,715,866 Project Grant award from the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) aims to develop a new understanding of the early progression of pulmonary fibrosis (PF) and identify strategies for early disease detection and prevention. The 5-year program consists of 4 research projects and 3 supporting cores at the University of Michigan and its sub-awardees, Vanderbilt University Medical Center and Translational Genomics Research Institute....
This Project Grant award from the National Institute of Environmental Health Sciences (NIEHS) under the Environmental Health (CFDA 93.113) program supports research to characterize the joint effects of early life lead exposure, other metal exposures, and psychosocial co-exposures on physiological stress and cardiometabolic health across the life course. The $107,493 award to the Regents of the University of Michigan aims to: 1) Examine the combined impacts of heavy metals, socioeconomic...
The federal Project Grant award R35HL176572 was provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research (CFDA 93.837) program. The $1,061,189 grant, awarded on January 1, 2025, supports research at the University of Michigan focused on immune crosstalk in lung injury and fibrosis. Key objectives include studying epithelial cell regulation of fibrosis, mechanisms for impaired innate immunity against gram-positive infections in fibrosis, and...

This Project Grant award from the National Institute of Environmental Health Sciences (NIEHS), under the Environmental Health (CFDA 93.113) federal grant program, provides $526,627 to the Regents of the University of Michigan to conduct research on the mechanisms driving fibrosis in response to silica and asbestos inhalation. The research aims to elucidate how specific signaling pathways prevent alveolar epithelial cell differentiation, leading to non-resolving fibrosis in silicosis and asbestosis. Key activities include defining subsets of transitional alveolar epithelial cells, performing lineage tracing to understand cell fate determination, and investigating signaling mechanisms regulating fibroblast activation. The award period runs from June 2025 to March 2030.

Generated 7/15/25, 8:13 AM